Results 91 to 100 of about 1,831 (125)

Androgen receptor signaling as a new target for intervention in acute myeloid leukemia. [PDF]

Blood Adv
Qian F, Sarkar D, Arner BE, Peduzzi VM, Bai Y, Ruan B, Jia B, Zheng H, Paulson RF, Prabhu KS.   +9 more
europepmc   +1 more source

Clinical Profile and Plasma Vitamin B6 Levels in Children with Tourette Syndrome: A Case-control Study. [PDF]

Indian J Psychol Med
Kumar AA, Shaju A, Mubashira V, Balan S, Vidyadharan V, Dhananjayan D, Ravindren R.   +6 more
europepmc   +1 more source

The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations. [PDF]

Healthcare (Basel)
Shaw J, Lai C, Bota P, Le A, Andricioaei A, Tran T, Allee T.   +6 more
europepmc   +1 more source

Stem cell-based approaches for alopecia: A narrative review of current and emerging treatment strategies. [PDF]

Cell Transplant
Paphawannasri P, Tawonsawatruk T, Phetfong J, Supokawej A.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Post-Finasteride Syndrome. Literature Review

Archivos Espanoles De Urologia, 2022
Post-finasteride syndrome (PFS) is a little known adverse effect of 5α-reductase inhibitor (5-ARI) drugs used in benign prostatic hyperplasia (BPH) and androgenetic alopecia. Five articles on the syndrome have been published in Spain, although no review has been published.The objectives of this article are to review the world literature, including the ...
exaly   +3 more sources

Post-finasteride Syndrome: A Review of Current Literature

Current Sexual Health Reports, 2018
A constellation of persistent adverse effects—collectively termed post-finasteride syndrome (PFS)—after 5α-reductase inhibitor treatment for benign prostatic hyperplasia (BPH) and androgenic alopecia (AGA) has recently been described. The severity of these sexual, physical, neurological, and psychiatric side effects raises important concerns regarding ...
, Khera Mohit
exaly   +2 more sources

Trazodone by epigenetic mechanism can reverse the post finasteride syndrome

Magna Scientia Advanced Research and Reviews, 2023
The action mechanism of finasteride as inhibitor of the 5alpha-reductase enzyme in the brain could cause an epigenetic change imbalance in the messenger RNA of androgen receptor. The decrease of dihydrotestosterone (DHT) followed by an increase of free testosterone in the brain could in theory cause an imbalance in acetylation and methylation of ...
exaly   +2 more sources

The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption

Current Sexual Health Reports, 2018
Post-finasteride syndrome (PFS) is a disorder characterized by a set of clinical symptoms experienced during use or after drug discontinuation. This cluster of symptoms encompasses overall sexual dysfunction (SD), erectile dysfunction (ED), loss of libido, depression, suicidal ideation, anxiety, panic attacks, insomnia, and cognitive dysfunction.
Abdulmaged Traish, Traish Abdulmaged M
exaly   +2 more sources

Post-Finasteride Syndrome

2022
Faysal Yafi, Yacov Reisman, Reisman Yacov   +2 more
exaly   +2 more sources

Post‐finasteride syndrome: real or myth?

Trends in Urology & Men's Health
Men who report persistent sexual, neurological, and psychological side‐effects after discontinuing finasteride are said to have post‐finasteride syndrome. It is uncommon, but difficult for men suffering its effects. Although controversial, with no proven treatments, the syndrome should not be ignored.
exaly   +2 more sources